Clinical Trial Update: A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated BIBR 1048 for prevention of venous thromboembolism in patients undergoing total knee replacement, with results posted in December 2010…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• BIBR 1048

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthroplasty, Replacement, Knee, Venous Thrombosis | Phase 2 | Status: COMPLETED | Results posted: 2010-12-17